Facilitated By

San Antonio Medical Foundation

News

  • US appeals court rejects Nasdaq's diversity rules for company boards - MySA

    Official Inspection Station in San Antonio is one of many companies feeling the effects of the ... biotech and industrial companies as well.

  • Director Harmon Cyrus was granted 29,250 shares and sold $147,956 worth of ... - Quantisnow

    ... San Antonio Breast Cancer Symposium (SABCS) in December Strong cash ... Biotechnology: Pharmaceutical Preparations. Health Care. Medical/Nursing ...

  • LYNPARZA® (olaparib) demonstrated clinically meaningful prolonged survival benefit ... - BioSpace

    These results were presented today at the San Antonio Breast Cancer ... Sarepta, Biotech's Regulatory Go-Getter, Signs Standout Rare Disease Deal.

  • Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in ...

    Gonzalez Convention Center in San Antonio, Texas. ‌. The poster presents ... Celcuity is a clinical-stage biotechnology company focused on ...

  • Breast cancer researcher receives outstanding investigator award - Healio

    SAN ANTONIO — Christina Curtis, PhD, MSc, received this year's AACR ... The work can be conducted in any biomedical research discipline, including ...